| Cancer stem cells and immunosuppressive microenvironment in glioma Q Ma, W Long, C Xing, J Chu, M Luo, HY Wang, Q Liu, RF Wang Frontiers in immunology, 2924, 2018 | 178 | 2018 |
| Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1 Y Zhu, Y Liu, C Zhang, J Chu, Y Wu, Y Li, J Liu, Q Li, S Li, Q Shi, L Jin, ... Nature communications 9 (1), 1-11, 2018 | 114 | 2018 |
| NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2 P Hu, J Chu, Y Wu, L Sun, X Lv, Y Zhu, J Li, Q Guo, C Gong, B Liu, S Su Oncotarget 6 (32), 32410, 2015 | 98 | 2015 |
| Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication J Chu, C Xing, Y Du, T Duan, S Liu, P Zhang, C Cheng, J Henley, X Liu, ... Nature Metabolism, 1-10, 2021 | 84 | 2021 |
| Microbiota regulate innate immune signaling and protective immunity against cancer C Xing, M Wang, AA Ajibade, P Tan, C Fu, L Chen, M Zhu, ZZ Hao, J Chu, ... Cell Host & Microbe 29 (6), 959-974. e7, 2021 | 75 | 2021 |
| E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter J Chu, Y Zhu, Y Liu, L Sun, X Lv, Y Wu, P Hu, F Su, C Gong, E Song, B Liu, ... Oncotarget 6 (31), 31944, 2015 | 73 | 2015 |
| The C/EBPβ-LINC01133 axis promotes cell proliferation in pancreatic ductal adenocarcinoma through upregulation of CCNG1 CS Huang, J Chu, XX Zhu, JH Li, XT Huang, JP Cai, W Zhao, XY Yin Cancer letters 421, 63-72, 2018 | 52 | 2018 |
| Multifunctional nanoparticles for co-delivery of paclitaxel and carboplatin against ovarian cancer by inactivating the JMJD3-HER2 axis J Mo, L Wang, X Huang, B Lu, C Zou, L Wei, J Chu, PK Eggers, S Chen, ... Nanoscale 9 (35), 13142-13152, 2017 | 49 | 2017 |
| Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1–miR-593-5p–MFF axis S Fan, B Liu, L Sun, X Lv, Z Lin, W Chen, W Chen, Q Tang, Y Wang, Y Su, ... Oncotarget 6 (17), 14885, 2015 | 48 | 2015 |
| The role of APAL/ST8SIA6-AS1 lncRNA in PLK1 activation and mitotic catastrophe of tumor cells ML Luo, J Li, L Shen, J Chu, Q Guo, G Liang, W Wu, J Chen, R Chen, ... JNCI: Journal of the National Cancer Institute 112 (4), 356-368, 2020 | 44 | 2020 |
| Treatment of metastatic non‑small cell lung cancer with NY‑ESO‑1 specific TCR engineered‑T cells in a phase I clinical trial: A case report Y Xia, X Tian, J Wang, D Qiao, X Liu, L Xiao, W Liang, D Ban, J Chu, J Yu, ... Oncology letters 16 (6), 6998-7007, 2018 | 44 | 2018 |
| PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4 W Long, W Zhao, B Ning, J Huang, J Chu, L Li, Q Ma, C Xing, HY Wang, ... Journal of molecular cell biology 10 (2), 147-160, 2018 | 29 | 2018 |
| Regulation of SOX10 stability via ubiquitination-mediated degradation by Fbxw7α modulates melanoma cell migration XB Lv, W Wu, X Tang, Y Wu, Y Zhu, Y Liu, X Cui, J Chu, P Hu, J Li, Q Guo Oncotarget 6 (34), 36370, 2015 | 24 | 2015 |
| Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy X Liu, Y Xu, W Xiong, B Yin, Y Huang, J Chu, C Xing, C Qian, Y Du, ... Journal for immunotherapy of cancer 10 (3), 2022 | 23 | 2022 |
| JMJD3 regulates CD4+ T cell trafficking by targeting actin cytoskeleton regulatory gene Pdlim4 C Fu, Q Li, J Zou, C Xing, M Luo, B Yin, J Chu, J Yu, X Liu, HY Wang, ... The Journal of clinical investigation 129 (11), 4745-4757, 2019 | 21 | 2019 |
| Terrein performs antitumor functions on esophageal cancer cells by inhibiting cell proliferation and synergistic interaction with cisplatin Y Wu, Y Zhu, S Li, M Zeng, J Chu, P Hu, J Li, Q Guo, XB Lv, G Huang Oncology letters 13 (4), 2805-2810, 2017 | 20 | 2017 |
| Interaction Between Microbiota and Immunity and Its Implication in Colorectal Cancer C Xing, Y Du, T Duan, K Nim, J Chu, HY Wang, RF Wang Frontiers in Immunology, 4163, 2022 | 12 | 2022 |
| Activation of cGASSTING by Lethal Malaria N67C Dictates Immunity and Mortality through Induction of CD11b+Ly6Chi Proinflammatory Monocytes Y Du, Y Luo, Z Hu, J Lu, X Liu, C Xing, J Wu, T Duan, J Chu, HY Wang, ... Advanced Science, 2103701, 2022 | 11 | 2022 |
| Dynamic Tumor-Specific MHC-II Immuno-PET Predicts the Efficacy of Checkpoint Inhibitor Immunotherapy in Melanoma Z Yang, F Li, Y Huang, N Yin, J Chu, Y Ma, RI Pettigrew, DJ Hamilton, ... Journal of Nuclear Medicine 63 (11), 1708-1714, 2022 | 3 | 2022 |
| USP3 plays a critical role in the induction of innate immune tolerance T Duan, Y Feng, Y Du, C Xing, J Chu, J Ou, X Liu, M Zhu, C Qian, B Yin, ... EMBO reports, e57828, 2023 | 2 | 2023 |
Changsheng XingAssistant Professor of Research, University of Southern California在 usc.edu 的电子邮件经过验证
